Market Cap (In INR)
418.7 Billion
Revenue (In INR)
147.55 Billion
Net Income (In INR)
10.22 Billion
Avg. Volume
5.19 Million
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 239.3-395.8
- PE
- -
- EPS
- -
- Beta Value
- 0.464
- ISIN
- INE376G01013
- CUSIP
- Y0905C102
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Siddharth Mittal BCom, CA, CPA
- Employee Count
- -
- Website
- https://www.biocon.com
- Ipo Date
- 2004-04-07
- Details
- Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and manufacturing services for small and large molecules. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.
More Stocks
-
TRAWTraws Pharma, Inc.
TRAW
-
YAK
-
ASSAMENTAssam Entrade Limited
ASSAMENT
-
RANEHOLDINRane Holdings Limited
RANEHOLDIN
-
002410
-
SCG
-
SWEC-ASweco AB (publ)
SWEC-A
-
INN